Comparing two injected drugs for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study compares two injectable medications, RAY1225 and semaglutide, added to your usual diabetes pills, to see how well they control blood sugar and affect weight. It aims to help improve glucose control in people with type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 2 diabetes.
- Your average blood sugar (A1C) should be between 7.0% and 11.5%.
- Your body mass index (BMI) must be 20 or higher (a measure of body fat based on height and weight).
- Your weight should have been steady (within 5%) for the past 12 weeks.
- You must not have type 1 diabetes or serious eye problems from diabetes that need urgent treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called RAY1225, given as a once-weekly injection, to help lower blood sugar in adults with type 2 diabetes. It is for people who have not been on diabetes medications recently or have only taken oral medications before, and who have not started insulin.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
This study tests a new medication called PG-102 against a placebo and an existing medication (semaglutide) to see how well it controls blood sugar in people with type 2 diabetes. It may offer a new treatment option that could help lower your blood sugar levels.
This study tests a new medication called semaglutide (similar to Ozempic) in people with type 2 diabetes who are already taking metformin. It aims to see if this medication improves blood sugar control and may also help with weight loss.
This study compares two newer once-weekly injectable medicines to see which one works better for lowering blood sugar in people with type 2 diabetes. You may join if your blood sugar is not well controlled on your current diabetes pills.
Hear when a new T2DM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.